Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk pros...
Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer
About this item
Full title
Author / Creator
Publisher
Poland: Termedia Publishing House
Journal title
Language
English
Formats
Publication information
Publisher
Poland: Termedia Publishing House
Subjects
More information
Scope and Contents
Contents
Recent retrospective data suggest that brachytherapy (BT) boost may confer a cancer-specific survival benefit in radiation-managed high-risk prostate cancer. We sought to determine whether this survival benefit would extend to the recently defined favorable high-risk subgroup of prostate cancer patients (T1c, Gleason 4 + 4 = 8, PSA < 10 ng/ml or T1...
Alternative Titles
Full title
Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4f7b7c58aca1449b944d47fc011f0036
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4f7b7c58aca1449b944d47fc011f0036
Other Identifiers
ISSN
1689-832X
E-ISSN
2081-2841
DOI
10.5114/jcb.2016.58080
